Apollo Hospital, one of India's largest hospital chains, has announced a new partnership to develop more AI tools to predict the risk of cardiovascular disease.
Collaborate with 3M spinoff Solventum Health Information Systems Use patient classification and quality methodology to enhance cardiovascular care. Specifically, the solventum tools will be integrated with Apollo's AI-driven cardiovascular disease risk technology.
They will later work to assess the effectiveness of combined solutions for population health and resource efficiency indicators, including mortality, length of stay, complications, and readmissions.
“The purpose of this project is to assess opportunities to deliver high quality care in the most cost-effective way by leveraging the potential of diagnostic-related groups, case mix indexes, and disease severity and increasing the efficiency of resource utilization,” their media release read.
Why is it important?
The partnership focuses on cardiovascular disease, a major cause of premature death and morbidity in India. Along with the continued severe cardiologist shortage, the increased burden (cardiovascular disease accounts for more than a quarter of deaths in the country), now with one cardiologist per 250,000 people, the use of predictive analytics is becoming more important to fill this gap.
Enhanced Apollo's predictive analytics tools are expected to increase Apollo's capabilities and to identify patients when they are at risk of adverse outcomes and further hospitalization.
Larger context
Apollo introduced it Cardiovascular disease risk tool for 2021. Built using data from over 400,000 patients, the tool considers lifestyle attributes and vital signs to predict individual risk of cardiovascular disease.
The following year, the forecasting tool was Integrated with ConnectedLife, Healthcare Applications and Fitbit Partners in Singapore.
In addition to predictive analysis of cardiovascular care, hospital chains have pursued a variety of AI projects over the past few years. Recently, it is reported that Apollo Hospital is planning We will adopt AI Copilots from Microsoft as part of our new partnership to support the implementation of our AI roadmap.
record
“This powerful union allows us to more accurately identify high-risk patients and achieve timely, personalized care. This breakdown leads to dramatic reductions in complications and hospital stays, fundamentally transforming patient outcomes and expanding access to high quality care that is suitable for all individuals.
“We believe this collaboration will help us to more accurately identify patients at high risk of adverse outcomes that may require additional services. We expect clinical outcomes as a result of improved patient access, operational efficiency and joint efforts,” DR added. Sandeep Wadhwa, Global Chief Medical Officer of Solventum His.
